局部晚期胃癌患者中存在不完全DPYD单倍型B3：重新考虑5-氟尿嘧啶剂量策略。 - Suppr

Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy.

作者信息

Dierks Sascha, Buchholz Sören Matthias, König Alexander, Liersch Torsten, Schanz Julie

机构信息

Department for Clinical Chemistry, University Medical Center of Göttingen, Göttingen, Germany.

Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center of Göttingen, Göttingen, Germany.

出版信息

Eur J Cancer. 2024 Jun;204:114076. doi: 10.1016/j.ejca.2024.114076. Epub 2024 Apr 20.

DOI:10.1016/j.ejca.2024.114076

PMID:38663223

Abstract

摘要

相似文献

Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy.

Eur J Cancer. 2024 Jun;204:114076. doi: 10.1016/j.ejca.2024.114076. Epub 2024 Apr 20.

Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment.

Pharmacogenomics. 2009 Jun;10(6):931-44. doi: 10.2217/pgs.09.28.

DPYD*5 gene mutation contributes to the reduced DPYD enzyme activity and chemotherapeutic toxicity of 5-FU: results from genotyping study on 75 gastric carcinoma and colon carcinoma patients.

Med Oncol. 2007;24(2):251-8. doi: 10.1007/BF02698048.

Patients homozygous for DPYD c.1129-5923C>G/haplotype B3 have partial DPD deficiency and require a dose reduction when treated with fluoropyrimidines.

Cancer Chemother Pharmacol. 2016 Oct;78(4):875-80. doi: 10.1007/s00280-016-3137-0. Epub 2016 Aug 20.

Thymidylate synthase (TYMS) and dihydropyrimidine dehydrogenase (DPYD) polymorphisms in the Korean population for prediction of 5-fluorouracil-associated toxicity.

Ther Drug Monit. 2007 Apr;29(2):190-6. doi: 10.1097/FTD.0b013e318040b1fe.

Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.

Clin Cancer Res. 2011 May 15;17(10):3455-68. doi: 10.1158/1078-0432.CCR-10-2209. Epub 2011 Apr 15.

A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variant.

Clin Pharmacol Ther. 2014 Feb;95(2):136. doi: 10.1038/clpt.2013.183. Epub 2013 Sep 13.

Response to "A case of 5-FU-related severe toxicity associated with the P.Y186C DPYD variant".

Clin Pharmacol Ther. 2014 Feb;95(2):137. doi: 10.1038/clpt.2013.207. Epub 2013 Oct 9.

Impact of dihydropyrimidine dehydrogenase on 5-fluorouracil treatment in cancer patients.

Eur J Med Res. 2003 May 30;8(5):226-8.

Polymorphisms of dihydropyrimidine dehydrogenase gene and clinical outcomes of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.

Chin Med J (Engl). 2012 Mar;125(5):741-6.

引用本文的文献

Unrecognized mutations in DPYD* 2 A wild-type rectal cancer patients receiving postoperative 5-FU-based chemotherapy - do they have a clinical impact?

Cancer Chemother Pharmacol. 2025 Jul 15;95(1):75. doi: 10.1007/s00280-025-04787-4.

Characterization of Reference Materials for DPYD: A GeT-RM Collaborative Project.

J Mol Diagn. 2024 Oct;26(10):864-875. doi: 10.1016/j.jmoldx.2024.06.004. Epub 2024 Jul 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献